BridgeMD
New treatment option for Pertussis (Whooping Cough)
Official title Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
ClinicalTrials.gov ID: NCT06827470
What this study is testing
What is Biological: Bordetella pertussis J820?
Biological: Bordetella pertussis J820 is an investigational medicine, being studied as a potential treatment for pertussis (whooping cough).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The overall goal of this study is to establish a PRN-deficient pertussis Controlled Human Infection Model (CHIM) that represents currently circulating isolates, in the context of a North American exposure (vaccination and infection) pedigree.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- To be eligible for the study, each participant must satisfy ALL of the following criteria:
- Age 18-50 years, inclusive.
- Good general health status, as determined by history and physical examination conducted no longer than 30 days prior to the challenge.
- Participants who, in the opinion of the Investigator, can and will comply with the requirements of the protocol (e.g., complete Diary Cards, return...
- Written informed consent obtained from the participant.
You likely can't join if
- Participants with ANY of the following criteria at the time of screening will be excluded:
- Underlying chronic medical condition requiring ongoing follow-up and monitoring by a physician (e.g., diabetes, seizure disorder).
- Underlying cardiac and/or pulmonary disease including hypertension, angina, prior myocardial infarction, asthma, emphysema, chronic bronchitis, and...
- Moderate or severe symptoms of health anxiety, anxiety, and mood symptoms. Self-reported current diagnosis of a major psychiatric illness, including...
- QT prolongation on electrocardiogram (EKG).
- History of everyday smoking/vaping in the last 2 years and/or current smoking/vaping more than once per week.
See the full eligibility criteria
Who can join
- To be eligible for the study, each participant must satisfy ALL of the following criteria:
- Age 18-50 years, inclusive.
- Good general health status, as determined by history and physical examination conducted no longer than 30 days prior to the challenge.
- Participants who, in the opinion of the Investigator, can and will comply with the requirements of the protocol (e.g., complete Diary Cards, return for follow-up visits).
- Written informed consent obtained from the participant.
- If a cis woman and/or gender divergent person is at risk of becoming pregnant has practiced adequate contraception for 28 days prior to challenge and has a negative pregnancy test on the day before B. pertussis...
- Documented hysterectomy
- Documented bilateral salpingectomy
- Documented bilateral oophorectomy
- Documented and current bilateral tubal ligation or occlusion
- Credible self-reported history of diagnosed infertility
- Hormone therapy (e.g., testosterone), provided it is administered consistently and medically assessed as sufficient to reduce pregnancy such that ovulation has ceased
- Any other condition, as determined by the Principal Investigator, that would render an individual incapable of becoming pregnant Adequate contraception is defined as a contraceptive method with a failure rate of \<1%...
- Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation: oral, intravaginal, or transdermal
- Progestogen-only hormonal contraception associated with inhibition of ovulation: oral, injectable, or implantable
- Intra-uterine device (IUD) with or without hormonal release
- Vasectomized partner, if this is the participant's sole partner and the partner has received a medical assessment of the surgical success
- Credible self-reported history of abstinence for at least 28 days prior to challenge
What rules you out
- Participants with ANY of the following criteria at the time of screening will be excluded:
- Underlying chronic medical condition requiring ongoing follow-up and monitoring by a physician (e.g., diabetes, seizure disorder).
- Underlying cardiac and/or pulmonary disease including hypertension, angina, prior myocardial infarction, asthma, emphysema, chronic bronchitis, and pulmonary tuberculosis.
- Moderate or severe symptoms of health anxiety, anxiety, and mood symptoms. Self-reported current diagnosis of a major psychiatric illness, including a schizophrenia spectrum disorder, bipolar disorder, posttraumatic...
- QT prolongation on electrocardiogram (EKG).
- History of everyday smoking/vaping in the last 2 years and/or current smoking/vaping more than once per week.
- Pregnant (known before or established at the time of screening using a urine-based test) or breastfeeding.
- Immunocompromised (with HIV/AIDS-positive or receiving immunosuppressive therapy involving steroids) or with any medical condition or medication that leads to a compromised immune system.
- Positive for hepatitis B or C by blood test.
- Vaccinated against pertussis within previous 5 years and/or \>7 cumulative doses from infancy to date of screening.
- Reported history of laboratory-confirmed pertussis infection, including having been exposed to B. pertussis in a Controlled Human Infection Model
- Antibody titer to pertussis toxin \>20 IU/mL (2x the lower limit of quantification (LLOQ)).
- Detection of B. pertussis in nasal samples prior to challenge using culture isolation and/or PCR detection, or detection of other respiratory infection.
- Living or working with (any form of close contact) any of the at-risk/vulnerable groups who are not up to date on their vaccination, specifically children \ 65 years of age who have not received a dose of Tdap vaccine...
- Known allergy to macrolides including azithromycin or erythromycin, history of Clostridium difficile within last 2 months.
- Any contraindication to receiving azithromycin.
- Taking any systemic antibiotic currently or within the previous 2 weeks.
- Currently taking terfenadine, astemizole, theophylline, or cimetidine.
- Poor venous access, as defined by inability to obtain venous blood after 3 venipuncture attempts.
- Recent (within 6 months) nasal or sinus surgery, recent use of intranasal steroids (4 weeks), or diagnosis with nasal polyps.
- Receipt of any investigational drug or vaccine within 6 months prior to challenge. An investigational vaccine is defined as a vaccine that is still being tested in clinical trials or one that has not yet been authorized...
- Receipt of any authorized vaccines within 2 weeks prior to challenge with B. pertussis in this study. (This is to avoid attributing any AEs from these vaccines to the B. pertussis challenge, which would skew the study...
- Previous moderate or severe respiratory infection that required hospitalization.
- Head trauma (e.g., fracture of the cribriform plate) within 1 year of screening.
- Any other finding that the Investigator considers will make the participant unsuitable for the study or unable to comply with the study requirements.
- Symptoms indicative of acute respiratory illness (such as fever, cough, difficulty breathing) identified during the physical examination done on Day -1 (check-in) or Study Day 1 before a participant is challenged.
- History of Bell's Palsy and/or facial paralysis.
- Receipt of facial cosmetic filler in the past 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Halifax, Nova Scotia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.